254 related articles for article (PubMed ID: 19020367)
1. Anthracycline-induced cardiomyopathy.
Simmons A; Vacek JL; Meyers D
Postgrad Med; 2008 Nov; 120(4):67-72. PubMed ID: 19020367
[TBL] [Abstract][Full Text] [Related]
2. Role of afterload reduction in the prevention of late anthracycline cardiomyopathy.
Silber JH
Pediatr Blood Cancer; 2005 Jun; 44(7):607-13. PubMed ID: 15795884
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic prevention of anthracycline-induced cardiomyopathy.
Maradia K; Guglin M
Cardiol Rev; 2009; 17(5):243-52. PubMed ID: 19690476
[TBL] [Abstract][Full Text] [Related]
4. Exposure to anthracyclines during childhood causes cardiac injury.
Lipshultz SE
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapeutics-induced heart failure].
Paulides M; Wojnowski L
Med Klin (Munich); 2007 Jul; 102(7):574-8. PubMed ID: 17634876
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology and diagnosis of cancer drug induced cardiomyopathy.
Zuppinger C; Timolati F; Suter TM
Cardiovasc Toxicol; 2007; 7(2):61-6. PubMed ID: 17652805
[TBL] [Abstract][Full Text] [Related]
7. Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done?
Granger CB
Circulation; 2006 Dec; 114(23):2432-3. PubMed ID: 17146002
[No Abstract] [Full Text] [Related]
8. Anthracycline-induced cardiotoxicity: clinical course, risk factors, pathogenesis, detection and prevention--review of the literature.
Wojtacki J; Lewicka-Nowak E; Leśniewski-Kmak K
Med Sci Monit; 2000; 6(2):411-20. PubMed ID: 11208348
[TBL] [Abstract][Full Text] [Related]
9. Strategies for reduction of anthracycline cardiac toxicity.
Speyer J; Wasserheit C
Semin Oncol; 1998 Oct; 25(5):525-37. PubMed ID: 9783592
[TBL] [Abstract][Full Text] [Related]
10. [Anthracycline-induced cardiomyopathy].
Roul G; Cohen C; Lieber A
Presse Med; 2009 Jun; 38(6):987-94. PubMed ID: 19423276
[TBL] [Abstract][Full Text] [Related]
11. Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies.
Wouters KA; Kremer LC; Miller TL; Herman EH; Lipshultz SE
Br J Haematol; 2005 Dec; 131(5):561-78. PubMed ID: 16351632
[TBL] [Abstract][Full Text] [Related]
12. Risk assessment and management of anthracycline and HER2 receptor inhibitor-induced cardiomyopathy.
Jahangir E; Shah S; Shum K; Baxter C; Fitzpatrick JD; Cole J; Gilliland Y; Polin NM
South Med J; 2015 Feb; 108(2):71-8. PubMed ID: 25688890
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of anthracycline cardiotoxicity in children treated for acute myeloid leukaemia: retrospective cohort study in a single centre in the United Kingdom.
Temming P; Qureshi A; Hardt J; Leiper AD; Levitt G; Ancliff PJ; Webb DK
Pediatr Blood Cancer; 2011 Apr; 56(4):625-30. PubMed ID: 21298750
[TBL] [Abstract][Full Text] [Related]
14. Anthracycline-Induced Cardiomyopathy in Adults.
Tan TC; Neilan TG; Francis S; Plana JC; Scherrer-Crosbie M
Compr Physiol; 2015 Jul; 5(3):1517-40. PubMed ID: 26140726
[TBL] [Abstract][Full Text] [Related]
15. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
Conklin KA
Integr Cancer Ther; 2005 Jun; 4(2):110-30. PubMed ID: 15911925
[TBL] [Abstract][Full Text] [Related]
16. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.
Minotti G; Menna P; Salvatorelli E; Cairo G; Gianni L
Pharmacol Rev; 2004 Jun; 56(2):185-229. PubMed ID: 15169927
[TBL] [Abstract][Full Text] [Related]
17. Pathology of late-onset anthracycline cardiomyopathy.
Bernaba BN; Chan JB; Lai CK; Fishbein MC
Cardiovasc Pathol; 2010; 19(5):308-11. PubMed ID: 19747852
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention.
Adams MJ; Lipshultz SE
Pediatr Blood Cancer; 2005 Jun; 44(7):600-6. PubMed ID: 15856486
[TBL] [Abstract][Full Text] [Related]
19. [Cardiotoxicity of anthracyclines].
Costache II; Petriş A
Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1200-7. PubMed ID: 22276470
[TBL] [Abstract][Full Text] [Related]
20. Anthracycline-induced cardiomyopathy.
Keefe DL
Semin Oncol; 2001 Aug; 28(4 Suppl 12):2-7. PubMed ID: 11552224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
